Top Institutions in Ophthalmology and Endocrinology
Institutions leading in this area combine expertise in ophthalmology, endocrinology, and neurodegenerative disease research, utilizing large clinical databases, prospective clinical trials, and translational laboratory studies to evaluate GLP-1RA effects on ocular tissues and disease progression.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in ophthalmic research with strong collaborations in neurodegenerative and metabolic disease, enabling pioneering studies on GLP-1RA effects in ocular neuroprotection and glaucoma.
-
#2
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its translational research in glaucoma and retinal diseases and has extensive experience in clinical trials assessing novel therapeutics including metabolic modulators like GLP-1RAs.
-
#3
Mayo Clinic
Rochester, MN
Mayo Clinic integrates multidisciplinary clinical care and research, with significant contributions to understanding systemic effects of diabetes medications including GLP-1RAs on ocular health and neurodegeneration.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in neuro-ophthalmology and metabolic disease research, conducting cutting-edge studies on GLP-1 receptor agonists’ neuroprotective roles in ocular diseases and systemic metabolic regulation.
-
#5
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology centers globally, with strong research in retinal diseases and glaucoma, including studies on novel pharmacologic agents such as GLP-1RAs.
